Fate Therapeutics Inc. buy EF Hutton Acquisition Co. I
Start price
01.03.23
/
50%
€5.72
Target price
01.03.24
€9.37
Performance (%)
26.81%
End price
02.03.24
€7.25
Summary
This prediction ended on 02.03.24 with a price of €7.25. The BUY prediction by EF_Hutton_Acquisitio finished with a performance of 26.81%. EF_Hutton_Acquisitio has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fate Therapeutics Inc. | 4.829% | 4.829% | 20.189% | -80.064% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% | 48.878% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% | 83.744% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% | 60.392% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% | 61.272% |
Comments by EF_Hutton_Acquisitio for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $10.00 price target on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von EF_Hutton_Acquisitio gewählte maximale Laufzeit wurde überschritten